The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Herbal medicine Eunkyo-san (Yinqiao-san) for COVID-19: A telemedicine case series

  • Jiyoon Won (Department of Meridian & Acupoint, College of Korean Medicine, Dong-eui University) ;
  • Changsop Yang (KM Science Research Division, Korea Institute of Oriental Medicine) ;
  • Seungho Lee (Gyeongbuk Korean Medicine Clinic) ;
  • He-Sol Lee (R&D Strategy Division, Korea Institute of Oriental Medicine) ;
  • Sungha Kim (KM Science Research Division, Korea Institute of Oriental Medicine)
  • Received : 2023.10.26
  • Accepted : 2023.11.15
  • Published : 2023.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Coronavirus disease 2019 (COVID-19) cases surged across South Korea during the omicron-variant wave. We aimed to report the effectiveness of herbal medicine administered through telemedicine consultations as an adjunctive therapy for COVID-19. Patients with confirmed COVID-19 who were self-isolating at home were provided telephone consultations through a Korean Medicine clinic between January and March 2022. On the basis of their dominant symptoms, the patients were prescribed Eunkyo-san for seven days. Patients were asked to evaluate the severity of their COVID-19 symptoms before and after treatment by numeric rating scale. Of ten patients, more than half of them reported cough, fever, headache, and sore throat on the first telephone consultation. Patients reported that all symptoms related to COVID-19 disappeared completely on the second consultation. No severe adverse events were identified. The results of this case series suggest that Eunkyo-san administration can be a beneficial adjunctive therapy for patients with COVID-19.

Keywords

Acknowledgement

This study was supported by the Korea Institute of Oriental Medicine (KSN1823211) and supported by Policy support project of Korean Medicine for the infectious disease, funded by the Ministry of Health and Welfare; This work was supported by Dong-eui University Grant.(202301270001)

References

  1. Cucinotta, D. & Vanelli, M. (2020). Who declares covid-19 a pandemic. Acta Biomed. 91(1). 157-160. https://doi.org/10.23750/abm.v91i1.9397 
  2. Thakur, V. & Ratho, R. K. (2022). Omicron (b.1.1.529): A new sars-cov-2 variant of concern mounting worldwide fear. J Med Virol. 94(5). 1821-1824. https://doi.org/10.1002/jmv.27541 
  3. Jung, Y. H., Ha, E. H., Choe, K. W., Lee, S., Jo, D. H. & Lee, W. J. (2022). Persistent symptoms after acute covid-19 infection in omicron era. J Korean Med Sci. 37(27). e213. https://doi.org/10.3346/jkms.2022.37.e213 
  4. Seok, H., Lim, S., Kim, J. Y., Park, C. H., Kim, J. H., Woo, M. L., et al. (2022). Infectivity of coronavirus disease 2019: A prospective cohort study in the korean metropolitan area. J Korean Med Sci. 37(14). e106. https://doi.org/10.3346/jkms.2022.37.e106 
  5. Lee, J. K. (2022). As the incidence of omicron increases, so will the number of deaths. Osong Public Health Res Perspect. 13(1). 1-3. https://doi.org/10.24171/j.phrp.2022.13.1.01 
  6. (2020). Managing covid-19 symptoms (including at the end of life) in the community: Summary of nice guidelines. Bmj. 369(m1461. https://doi.org/10.1136/bmj.m1461 
  7. Organization, W. H. (2022). Clinical management of covid-19: Living guideline, 15 september 2022. World Health Organization. 
  8. Jeon, S. R., Kang, J. W., Ang, L., Lee, H. W., Lee, M. S. & Kim, T. H. (2022). Complementary and alternative medicine (cam) interventions for covid-19: An overview of systematic reviews. Integr Med Res. 11(3). 100842. https://doi.org/10.1016/j.imr.2022.100842 
  9. Ren, J. L.Zhang, A. H. & Wang, X. J. (2020). Traditional chinese medicine for covid-19 treatment. Pharmacol Res. 155(104743. https://doi.org/10.1016/j.phrs.2020.104743 
  10. Zong, X., Liang, N., Wang, J., Li, H., Wang, D., Chen, Y., et al. (2022). Treatment effect of qingfei paidu decoction combined with conventional treatment on covid-19 patients and other respiratory diseases: A multi-center retrospective case series. Front Pharmacol. 13(849598. https://doi.org/10.3389/fphar.2022.849598 
  11. Zhang, L., Zheng, X., Bai, X., Wang, Q., Chen, B., Wang, H., et al. (2021). Association between use of qingfei paidu tang and mortality in hospitalized patients with covid-19: A national retrospective registry study. Phytomedicine. 85(153531. https://doi.org/10.1016/j.phymed.2021.153531 
  12. Jang, S., Kim, D., Yi, E., Choi, G., Song, M. & Lee, E. K. (2021). Telemedicine and the use of korean medicine for patients with covid-19 in south korea: Observational study. JMIR Public Health Surveill. 7(1). e20236. https://doi.org/10.2196/20236 
  13. Cao, L. H., Jia, X. Y., He, H. J., Wang, Z. Z., Zhao, Y. Y., Yang, X., et al. (2022). Using a system pharmacology method to search for the potential targets and pathways of yinqiaosan against covid-19. J Healthc Eng. 2022(9248674. https://doi.org/10.1155/2022/9248674 
  14. Kim, M. K., Lee, B., Choi, Y. Y., Um, J., Lee, K. S., Sung, H. K., et al. (2022). Clinical characteristics of 40 patients infected with the sars-cov-2 omicron variant in korea. J Korean Med Sci. 37(3). e31. https://doi.org/10.3346/jkms.2022.37.e31 
  15. Kim, H. S. (2021). Towards telemedicine adoption in korea: 10 practical recommendations for physicians. J Korean Med Sci. 36(17). e103. https://doi.org/10.3346/jkms.2021.36.e103 
  16. Boonstra, A. M., Stewart, R. E., Koke, A. J., Oosterwijk, R. F., Swaan, J. L., Schreurs, K. M., et al. (2016). Cut-off points for mild, moderate, and severe pain on the numeric rating scale for pain in patients with chronic musculoskeletal pain: Variability and influence of sex and catastrophizing. Front Psychol. 7(1466. https://doi.org/10.3389/fpsyg.2016.01466 
  17. Reich, A., Chatzigeorkidis, E., Zeidler, C., Osada, N., Furue, M., Takamori, K., et al. (2017). Tailoring the cut-off values of the visual analogue scale and numeric rating scale in itch assessment. Acta Derm Venereol. 97(6). 759-760. https://doi.org/10.2340/00015555-2642 
  18. Zhang, L., Ma, Y., Shi, N., Tong, L., Liu, S., Ji, X., et al. (2022). Effect of qingfei paidu decoction combined with western medicine treatments for covid-19: A systematic review and meta-analysis. Phytomedicine. 102(154166. https://doi.org/10.1016/j.phymed.2022.154166 
  19. Kim, H.-Y.Ha, S.-Y. & Song, I.-S. (2007). Three cases report of acute bronchiolitis children treated by eunkyosan-gamibang. The Journal of Pediatrics of Korean Medicine. 21(3). 205-214. 
  20. Lin, H., Wang, X., Liu, M., Huang, M., Shen, Z., Feng, J., et al. (2021). Exploring the treatment of covid-19 with yinqiao powder based on network pharmacology. Phytother Res. 35(5). 2651-2664. https://doi.org/10.1002/ptr.7012 
  21. Lee, H., Kang, B., Hong, M., Lee, H. L., Choi, J. Y. & Lee, J. A. (2020). Eunkyosan for the common cold: A prisma-compliment systematic review of randomised, controlled trials. Medicine (Baltimore). 99(31). e21415. https://doi.org/10.1097/md.0000000000021415 
  22. Zhang, Y. & Li, Y. (2022). Exploring the clinical significance of yinqiao powder based on the compatibility of chinese herbal formulas. Med Theor Hypothesis. 5(1). 1. 
  23. Wong, W.Lam, C. L. & Fong, D. Y. (2012). Treatment effectiveness of two chinese herbal medicine formulae in upper respiratory tract infections--a randomized double-blind placebo-controlled trial. Fam Pract. 29(6). 643-652. https://doi.org/10.1093/fampra/cms027 
  24. Gonzalez Saenz de Tejada, M., Escobar, A., Bilbao, A., Herrera-Espineira, C., Garcia-Perez, L., Aizpuru, F., et al. (2014). A prospective study of the association of patient expectations with changes in health-related quality of life outcomes, following total joint replacement. BMC Musculoskelet Disord. 15(248. https://doi.org/10.1186/1471-2474-15-248 
  25. Park, J. H.Lee, S.Kim, T. H.Kim, S. & Lee, J. H. (2020). Current status of case reports and case series reported by korean medicine doctors in primary clinics: A systematic review. Integr Med Res. 9(4). 100417. https://doi.org/10.1016/j.imr.2020.100417